DUXAP2

Across TCGA pan-cancer cohorts, DUXAP2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated DUXAP2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher DUXAP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DUXAP2 expression acts as an unfavorable survival marker.

STAD, MESO, and BLCA are the cancer types where DUXAP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.460	0.748	.001	75	view →
MESO	OS	Tertile	All	0.052	0.528	.016	63	view →
BLCA	DFS	Median	II,III,IV	0.547	0.653	.014	51	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
READ	OS	Tertile	III,IV	0.111	0.890	<.001	36	view →
LGG	OS	Tertile	All	0.550	0.891	<.001	24	view →
BRCA	OS	Tertile	IV	0.402	0.800	.022	21	view →
KIRC	DFS	Tertile	IV	0.085	0.631	.002	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
LIHC	OS	Tertile	III,IV	0.118	0.615	.003	18	view →
LUSC	DFS	Quartile	III,IV	0.414	0.701	.009	12	view →
SKCM	OS	Tertile	II,III,IV	0.589	0.741	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

DUXAP2–STAD (DFS)

Open the STAD breakdown →